{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:51:55Z","timestamp":1791255115431,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite its widespread use, several aspects of procalcitonin (PCT) kinetics remain unclear for guiding antibiotic therapy, particularly its behavior in acute kidney injury (AKI) and during renal replacement therapy (RRT). This study aimed to describe PCT kinetics in intensive care unit (ICU) patients with AKI, including those undergoing RRT, compared with patients without AKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center retrospective study including 396 ICU patients. At admission, PCT, C-reactive protein (CRP), and white blood cell (WBC) count were compared across AKI stages. During ICU stay, any subsequent rise in PCT\u2009&gt;\u20092\u00a0\u00b5g\/L was defined as a PCT peak-episode. PCTpeak was the highest value before a sustained decline, PCTvalley the following lowest value, and PCTdecay the average daily reduction from peak to valley. Group comparisons were conducted using ANOVA or Kruskal\u2013Wallis tests, with Bonferroni correction as appropriate. Linear mixed-effects models were applied to account for repeated measures within patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CRP and WBC did not differ among AKI stages, whereas PCT increased progressively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). PCTpeak correlated with AKI severity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), while PCTdecay decreased progressively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Among stage 3 patients, RRT was performed in 12.3% of cases and did not significantly affect daily PCT levels compared to non-RRT patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AKI is associated with higher PCT peaks and reduced PCT decline, whereas RRT does not appear to significantly alter PCT kinetics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s44158-026-00405-8","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:04:57Z","timestamp":1783764297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Procalcitonin kinetics in critically ill patients: a retrospective analysis of the impact of renal dysfunction and renal replacement therapy"],"prefix":"10.1186","volume":"6","author":[{"given":"Francesco","family":"Cipulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Cazzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Casarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Miori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Balzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Anesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Bellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"12","key":"405_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy313","volume":"5","author":"Y Sakr","year":"2018","unstructured":"Sakr Y, Jaschinski U, Wittebole X et al (2018) Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis 5(12):ofy313","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"405_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181\u20131247","journal-title":"Intensive Care Med"},{"issue":"1","key":"405_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14(1):R15","journal-title":"Crit Care"},{"key":"405_CR4","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.12659\/MSM.910099","volume":"24","author":"N Gao","year":"2018","unstructured":"Gao N, Yan C, Zhang G (2018) Changes of serum procalcitonin (PCT), C-Reactive Protein (CRP), Interleukin-17 (IL-17), Interleukin-6 (IL-6), High mobility group protein-B1 (HMGB1) and D-dimer in patients with severe acute pancreatitis treated with continuous renal replacement therapy (CRRT) and its clinical significance. Med Sci Monit 24:5881\u20135886","journal-title":"Med Sci Monit"},{"issue":"7","key":"405_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41372-019-0363-4","volume":"39","author":"S Eschborn","year":"2019","unstructured":"Eschborn S, Weitkamp JH (2019) Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. J Perinatol 39(7):893\u2013903","journal-title":"J Perinatol"},{"key":"405_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15080975","author":"F Cipulli","year":"2025","unstructured":"Cipulli F, Balzani E, Marini G et al (2025) ICU \u2018magic numbers\u2019: the role of biomarkers in supporting clinical decision-making. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics15080975","journal-title":"Diagnostics (Basel)"},{"issue":"Suppl 1","key":"405_CR7","first-page":"S57","volume":"49","author":"P Maruna","year":"2000","unstructured":"Maruna P, Nedeln\u00edkov\u00e1 K, G\u00fcrlich R (2000) Physiology and genetics of procalcitonin. Physiol Res 49(Suppl 1):S57-61","journal-title":"Physiol Res"},{"issue":"3","key":"405_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7150\/ijms.39367","volume":"17","author":"R Paudel","year":"2020","unstructured":"Paudel R, Dogra P, Montgomery-Yates AA et al (2020) Procalcitonin: a promising tool or just another overhyped test? Int J Med Sci 17(3):332\u2013337","journal-title":"Int J Med Sci"},{"issue":"2","key":"405_CR9","first-page":"59","volume":"38","author":"I Samsudin","year":"2017","unstructured":"Samsudin I, Vasikaran SD (2017) Clinical utility and measurement of procalcitonin. Clin Biochem Rev 38(2):59\u201368","journal-title":"Clin Biochem Rev"},{"issue":"1","key":"405_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5114\/aoms.2016.57587","volume":"12","author":"M Lipi\u0144ska-Gediga","year":"2016","unstructured":"Lipi\u0144ska-Gediga M, Mierzcha\u0142a-Pasierb M, Durek G (2016) Procalcitonin kinetics - prognostic and diagnostic significance in septic patients. Arch Med Sci 12(1):112\u2013119","journal-title":"Arch Med Sci"},{"issue":"1","key":"405_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.46497\/ArchRheumatol.2024.9940","volume":"39","author":"V Ecesoy","year":"2024","unstructured":"Ecesoy V, Ecesoy H (2024) Is procalcitonin elevation always an indicator of bacterial infection? Arch Rheumatol 39(1):133\u2013135","journal-title":"Arch Rheumatol"},{"issue":"4","key":"405_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/23744235.2019.1704860","volume":"52","author":"B Tujula","year":"2020","unstructured":"Tujula B, H\u00e4m\u00e4l\u00e4inen S, Kokki H et al (2020) Review of clinical practice guidelines on the use of procalcitonin in infections. Infect Dis (Lond) 52(4):227\u2013234","journal-title":"Infect Dis (Lond)"},{"key":"405_CR13","volume":"2014","author":"MB Mat Nor","year":"2014","unstructured":"Mat Nor MB, Md Ralib A (2014) Procalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis. Crit Care Res Pract 2014:819034","journal-title":"Crit Care Res Pract"},{"issue":"1","key":"405_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12879-021-06064-0","volume":"21","author":"S Cong","year":"2021","unstructured":"Cong S, Ma T, Di X et al (2021) Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis. BMC Infect Dis 21(1):384","journal-title":"BMC Infect Dis"},{"issue":"9713","key":"405_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463\u2013474","journal-title":"Lancet"},{"key":"405_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf336","author":"S Gupta","year":"2025","unstructured":"Gupta S, Klompas M, Rhee C (2025) Reassessing procalcitonin-guided antibiotic therapy in critically ill patients with sepsis: lessons from the ADAPT-Sepsis Trial. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaf336","journal-title":"Clin Infect Dis"},{"issue":"4","key":"405_CR17","doi-asserted-by":"publisher","first-page":"230A","DOI":"10.1378\/chest.1388314","volume":"142","author":"V Jona","year":"2012","unstructured":"Jona V, Bharadwaj R, Swindler J et al (2012) False negative procalcitonin levels in patients with positive blood cultures. Chest 142(4):230A","journal-title":"Chest"},{"issue":"5","key":"405_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C Wacker","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM et al (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13(5):426\u2013435","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"405_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00508-004-0279-6","volume":"116","author":"G Steinbach","year":"2004","unstructured":"Steinbach G, B\u00f6lke E, Gr\u00fcnert A et al (2004) Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 116(24):849\u2013853","journal-title":"Wien Klin Wochenschr"},{"issue":"24","key":"405_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247274","volume":"11","author":"O de la Varga-Mart\u00ednez","year":"2022","unstructured":"de la Varga-Mart\u00ednez O, Mart\u00edn-Fern\u00e1ndez M, Heredia-Rodr\u00edguez M et al (2022) Influence of renal dysfunction on the differential behaviour of procalcitonin for the diagnosis of postoperative infection in cardiac surgery. J Clin Med 11(24):7274","journal-title":"J Clin Med"},{"issue":"2","key":"405_CR21","doi-asserted-by":"publisher","first-page":"ofu068","DOI":"10.1093\/ofid\/ofu068","volume":"1","author":"D El-sayed","year":"2014","unstructured":"El-sayed D, Grotts J, Golgert WA et al (2014) Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment. Open Forum Infect Dis 1(2):ofu068","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"405_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/ndt\/16.5.975","volume":"16","author":"S Herget-Rosenthal","year":"2001","unstructured":"Herget-Rosenthal S, Marggraf G, Pietruck F et al (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16(5):975\u2013979","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"405_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41291-1","volume":"9","author":"K Chun","year":"2019","unstructured":"Chun K, Chung W, Kim AJ et al (2019) Association between acute kidney injury and serum procalcitonin levels and their diagnostic usefulness in critically ill patients. Sci Rep 9(1):4777","journal-title":"Sci Rep"},{"issue":"3","key":"405_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0310057X0203000302","volume":"30","author":"AA Dahaba","year":"2002","unstructured":"Dahaba AA, Elawady GA, Rehak PH et al (2002) Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesth Intensive Care 30(3):269\u2013274","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"405_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000478965","volume":"44","author":"T Eichhorn","year":"2017","unstructured":"Eichhorn T, Hartmann J, Harm S et al (2017) Clearance of selected plasma cytokines with continuous veno-venous hemodialysis using Ultraflux EMiC2 versus Ultraflux AV1000S. Blood Purif 44(4):260\u2013266","journal-title":"Blood Purif"},{"key":"405_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2019.06.010","volume":"496","author":"E Aloisio","year":"2019","unstructured":"Aloisio E, Dolci A, Panteghini M (2019) Procalcitonin: between evidence and critical issues. Clin Chim Acta 496:7\u201312","journal-title":"Clin Chim Acta"},{"issue":"3","key":"405_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s10157-018-1639-2","volume":"23","author":"S Kubo","year":"2019","unstructured":"Kubo S, Iwasaki M, Horie M et al (2019) Biological variation of procalcitonin levels in hemodialysis patients. Clin Exp Nephrol 23(3):402\u2013408","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"405_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3343\/alm.2014.34.4.263","volume":"34","author":"M Meisner","year":"2014","unstructured":"Meisner M (2014) Update on procalcitonin measurements. Ann Lab Med 34(4):263\u2013273","journal-title":"Ann Lab Med"},{"key":"405_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5114\/aoms.2016.59264","volume":"2","author":"A Perrakis","year":"2016","unstructured":"Perrakis A, Stirkat F, Croner RS et al (2016) Prognostic and diagnostic value of procalcitonin in the post-transplant setting after liver transplantation. Arch Med Sci 2:372\u2013379","journal-title":"Arch Med Sci"},{"issue":"1","key":"405_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, Group ftKAGW (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204","journal-title":"Crit Care"},{"key":"405_CR31","doi-asserted-by":"publisher","unstructured":"Meisner M, Schmidt J, H\u00fcttner H, Tschaikowsky K (2000) The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 26;Suppl 2:S212\u2013S216. https:\/\/doi.org\/10.1007\/BF02900740","DOI":"10.1007\/BF02900740"},{"key":"405_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200102000-00004","author":"M Meisner","year":"2001","unstructured":"Meisner M, Lohs T, Huettemann E et al (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol. https:\/\/doi.org\/10.1097\/00003643-200102000-00004","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"405_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13054-019-2464-z","volume":"23","author":"PM Honore","year":"2019","unstructured":"Honore PM, De Bels D, Attou R et al (2019) The challenge of removal of sepsis markers by continuous hemofiltration. Crit Care 23(1):173","journal-title":"Crit Care"},{"key":"405_CR34","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.12659\/MSM.896819","volume":"22","author":"G Kade","year":"2016","unstructured":"Kade G, Lubas A, Rzeszotarska A et al (2016) Effectiveness of high cut-off hemofilters in the removal of selected cytokines in patients during septic shock accompanied by acute kidney injury-preliminary study. Med Sci Monit 22:4338\u20134344","journal-title":"Med Sci Monit"},{"issue":"10","key":"405_CR35","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s001340051041","volume":"25","author":"T Nishikura","year":"1999","unstructured":"Nishikura T (1999) The clearance of procalcitonin (PCT) during continuous veno-venous hemodiafiltration (CVVHD). Intensive Care Med 25(10):1198\u20131199","journal-title":"Intensive Care Med"},{"issue":"6","key":"405_CR36","doi-asserted-by":"publisher","first-page":"R160","DOI":"10.1186\/cc2372","volume":"7","author":"C Level","year":"2003","unstructured":"Level C, Chauveau P, Guisset O et al (2003) Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 7(6):R160","journal-title":"Crit Care"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-026-00405-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00405-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00405-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:15:47Z","timestamp":1791252947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44158-026-00405-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1186\/s44158-026-00405-8","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board (\u2018Comitato Etico per le Sperimentazioni Cliniche of the Azienda Provinciale per i Servizi Sanitari di Trento\u2019, approval number #12795). Informed consent was obtained a posteriori from surviving patients. For non-survivors, data were included under a waiver of consent as approved by the institutional review board.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}